The Src Family of Protein Tyrosine Kinases: A New and Promising Target for Colorectal Cancer Therapy
- 30 April 2010
- journal article
- review article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 9 (2), 89-94
- https://doi.org/10.3816/ccc.2010.n.012
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved ChemotherapyJournal of Clinical Oncology, 2009
- Synergistic Activity of the Src Family Kinase Inhibitor Dasatinib and Oxaliplatin in Colon Carcinoma Cells Is Mediated by Oxidative StressCancer Research, 2009
- Src-Induced Cisplatin Resistance Mediated by Cell-to-Cell CommunicationCancer Research, 2009
- Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase–STAT3 BindingCancer Research, 2009
- Caveolin-1 in tumor progression: the good, the bad and the uglyCancer and Metastasis Reviews, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Research and Treatment, 2007
- Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian CarcinomaCancer Research, 2006
- Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinasesBritish Journal of Cancer, 2006
- Src kinase contributes to the metastatic spread of carcinoma cellsOncogene, 2002